Lung cancer is often thought to mainly affect smokers, but the truth is that a growing number of cases are being diagnosed in individuals who have never smoked. If we were to examine lung cancer cases among non-smokers alone, it would actually rank as one of the leading causes of cancer-related deaths. This challenges the traditional views surrounding the disease and highlights a significant gap in both public and medical awareness.
Several factors unrelated to tobacco contribute to this risk. Prolonged exposure to second-hand smoke, indoor air pollution from sources like biomass fuels, fine particulate matter (PM2.5), radon gas, and workplace carcinogens such as asbestos and silica all play a crucial role. Moreover, certain genetic factors and mutations (notably EGFR, ALK, and ROS1) are more prevalent in non-smokers, especially among women and individuals in Asian communities.
Clinically, lung cancer in non-smokers often goes undiagnosed until it reaches advanced stages because their symptoms are frequently dismissed, and screening guidelines tend to prioritize smokers. As a result, many people are only diagnosed when the disease has progressed, even though these tumors can sometimes behave differently and respond better to targeted therapies.
It’s essential to acknowledge the risk of lung cancer beyond smoking to facilitate early diagnosis, implement policy changes, and promote preventive measures. By expanding our understanding of risk factors, enhancing air quality, and integrating molecular profiling into standard medical practice, we could significantly improve outcomes for this often-overlooked group.
Lung cancer is not exclusively a smoker’s disease—environmental and genetic risks matter.
Should occupational and environmental exposure history be mandatory in risk stratification?
MBH/PS